Additional candidate is mangiferin, which is rich-in mango pulp and reported to protect hyperlipidemia through the regulation of metabolic pathways including metabolism of dicarboxylate, reduction of apoptosis, and β-cell regeneration including glucose transporter 2 (Glut-2) [44,45]. The gene discussed is SLC2A2; the disease is hyperlipidemia.